Bought AIS, in at 1.87.買認可機構,在在1.87 。


Antares Pharma, (AIS) develops, commercializes and markets novel delivery solutions, including needle-free and mini-needle injector systems, gel technologies and transdermal products. antares製藥,計劃( AIS )的發展,商業化和市場的新型交付解決方案,包括針自由和小針注射器系統,凝膠和透皮吸收技術的產品。